Growth performance and growth regulatory pathways were examined in juvenile gilthead sea bream fed diets containing largely plant-based ingredients. Four isonitrogenous and isolipidic extruded diets with a low level (20%) of fish meal inclusion were formulated with graded levels of a vegetable oil mixture (17:58:25 of rapeseed: linseed: palm oils) replacing fish oil at 33, 66 and 100% (33VO, 66VO and VO diets). All diets were supplemented with lysine (0.55%) and contained soy lecithin (1%). Daily growth coefficients and feed efficiency over the course of an 11-week trial were almost identical in fish fed the FO, 33VO and 66VO diets. The VO diet reduced feed intake and growth without significant effects in proximate whole body composition, nitrogen or energy retentions. The highest concentration of plasma levels of insulin-like growth factor-I (IGF-I) was found in fish fed the 33VO diet. The lowest concentration was attained in fish fed the VO diet, whereas intermediate values were found in fish fed FO and 66VO diets. An opposite trend was found for circulating levels of growth hormone (GH), probably as a result of a reduced negative feedback inhibition from circulating IGF-I. Hepatic expression of IGF-I and GH receptor type I (GHR-I) was regulated in concert and mRNA levels paralleled plasma levels of IGF-I. Hepatic IGF-II and GHR-II were expressed in a more constitutive manner and no changes at the mRNA level were detected. In the skeletal muscle, IGF-I and GHR-I mRNAs did not vary significantly among groups. By contrast, IGF-II mRNA was up-regulated in fish fed the control diet, whereas the highest amount of GHR-II mRNA was attained in fish fed the 66VO diet. All together, these results suggest different growth compensatory mechanisms mediated by IGF-II and GHR-II at the local tissue level. These new insights prompted us to propose that practical diets low in marine ingredients can be used over the productive cycle of gilthead sea bream when essential fatty acids are supplied above the requirement levels.
Introduction 50 51
Currently, aquaculture is the major consumer of fish meal, a protein-dense feedstuff 52 that approximates the ideal amino acid profile of most cultured livestock. However, fish 53 meal is a limited resource whose availability has remained stable from the late 1980s at 54 approximately 6 million metric tonnes per annum, which limits the continuous growth of 55 aquaculture production (FAO, 2004) . Furthermore, inherent variability in fish meal 56 composition due to species, season, geographic origin and processing leads to variation in 57 quality (Opstvedt et al., 2003; Bragadóttir et al., 2004) , and most of the future changes in 58 developing novel aquafeeds should be focused on alternative protein sources. 59
The n-3 long-chain highly unsaturated fatty acids (n-3 HUFA) are naturally 60 abundant in the marine environment, and fish oil is the major source of eicosapentaenoic 61 acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 20:6n-3) for aquafeeds. Besides the 62 scarcity of fish oil, which is of great concern for marine fish, these animals have a limited 63 capacity to biosynthesize n-3 HUFA from the shorter chain linolenic acid (18:3n-3), and 64 both EPA and DHA become critical dietary constituents to ensure successful survival, 65 growth, and development of these fish (Sargent et al., 1999 (Sargent et al., , 2002 . At this standpoint, it 66 must be noted that fish meal also contains certain amounts of oil rich in n-3 HUFA, and the 67 fish oil added to energized diets can be totally replaced by vegetable oils when fish meal is 68 included at a high level in diets for Atlantic salmon (Bell et al., 2003; Bransden et al., 2003; 69 Torstensen et al., 2004) , rainbow trout (Richard et al., 2006a) , and the freshwater African 70 catfish (Ng et al., 2004) . Similar results have been achieved in a typically marine fish such 71 as turbot (Regost et al., 2003) . A high fish oil replacement is also feasible in the Murray 72 cod using casein-based diets (Francis et al., 2006) . Likewise, up to 60% of fish oil added to 73
GH and IGF-I radioimmunoassay 158 159
Plasma GH levels were assayed by a homologous gilthead sea bream 160 radioimmunoassay (RIA), using recombinant GH as tracer and standard (Martínez-161 Barberá et al., 1995) . Sensitivity and midrange of the assay were 0.1 ng/ml and 2.1 to 2.3 162 ng/ml, respectively. PrepStation (Applied Biosystems, CA, USA). Briefly, liver and white skeletal muscle were 175 homogenized at a ratio of 25 mg/ml with a guanidine-detergent lysis reagent. The reaction 176 mixture was treated with protease K, and RNA purification was achieved by passing the 177 tissue lysate (0.5 ml) through a purification tray containing an application-specific 178 membrane. Wash solutions containing DNase were applied, and total RNA was eluted into 179 a 96-well PCR plate. The RNA yield was 40-50 µg with absorbance measures (A 260/280 ) of 180 1.9 to 2.1. 181
Reverse transcription (RT) with random decamers was performed with the High-182
Capacity cDNA Archive Kit (Applied Biosystems). For this purpose, 500 ng total RNA 183 were reverse transcribed in a final volume of 100 µl. RT reactions were incubated 10 min at 184 25 ºC and 2 h at 37 ºC. Control reactions were run without reverse transcriptase and were 185 used as negative real-time PCR controls. 186 187 2.6. Real-time PCR 188 189 Real-time PCR was performed using an iCycler IQ Real-time Detection System 190 (Bio-Rad, Hercules, CA, USA) as previously described (Calduch-Giner et al., 2003) . 191 Diluted RT reactions were used for PCR reactions in 25 µl volume. Each PCR-well 192 contained SYBR Green Master Mix (Bio-Rad) with specific primers for target and 193 reference genes at a final concentration of 0.9 µM (see Table 4 ). 194
The efficiency of PCR reactions for target and reference genes varied between 87 195 and 97%. The dynamic range of standard curves (serial dilutions of RT-PCR reactions) 196 spanned five orders of magnitude, and the amount of product in a particular sample was 197 determined by interpolation of the cycle threshold (Ct) value. The specificity of reaction 198 was verified by analysis of melting curves and by electrophoresis and sequencing of PCR 199 amplified products. Reactions were performed in triplicate and fluorescence data acquired 200 during the extension phase were normalized to β-actin, using the delta-delta method (Livak 201 and Schmittgen, 2001 Diets 33VO and 66VO were well accepted by fish, and animals grew rapidly from 215 16 to 91-92 g over the course of the 11-week growth study (Table 5 ). No differences in feed 216 intake (69 to 67.5 g/fish), daily growth indices (2.66 to 2.68%), and feed (1.09 to 1.11) or 217 protein (2.21 to 2.25) efficiencies were found among control fish (FO) and fish fed 33VO 218 and 66VO diets. Total replacement of fish oil by the vegetable oil blend (diet VO) reduced 219 feed intake (61 g/fish) and daily growth indices (2.43%) without any significant effect on 220 whole body composition. Nitrogen (35 to 37%) and energy (50 to 52%) retentions were not 221 altered by dietary treatments, remaining high in all experimental groups. Lipid deposition 222 in mesenteric and liver depots was not affected significantly by dietary treatments, although 223 there was a trend for liver fat to increase with fish oil replacement. 224
At the end of the growth study, plasma levels of IGF-I were decreased over the 225 course of the post-pandrial period (P<0.05) (Fig. 1) . The highest IGF-I concentration was 226 found in fish fed the 33VO diet and the lowest in fish fed the VO diet irrespective of 227 sampling time (5 to 20 h postfeeding). Intermediate values were found in control fish and 228 fish fed the 66VO diet. 229
There was no significant effect of dietary treatment on plasma GH levels (Fig. 2) . 230 However, the trend was opposite to that of plasma IGF-I levels. First, the overall plasma 231 GH concentration increased over the course of post-pandrial period (P<0.05). Secondly, the 232 lowest GH concentration was found in fish fed the 33VO diet whereas increased values 233 were observed in fish fed the VO diet. 234
Hepatic IGF-I mRNA and plasma levels of IGF-I (20 h postfeeding) were positively 235 correlated (P< 0.05). The highest amount of IGF-I mRNA was found in fish fed the 33VO 236 diet with a progressive and significant decrease with additional fish oil replacement, 237 whereas control fish remained at intermediate values (Fig. 3A) . IGF-II was expressed at a 238 reduced level and no significant changes were found with dietary treatments, although the 239 trend for IGF-II mRNA was similar to that reported for IGF-I mRNA (Fig. 3B) . 240
Hepatic levels of GHR-I mRNA correlated positively with hepatic transcripts of 241 IGF-I and plasma levels of IGF-I (Fig. 4A) . Thus, GHR-I mRNA decreased progressively 242 and significantly with the graded replacement of fish oil in fish fed 33VO, 66VO and VO 243 diets. Intermediate values were found in fish fed diet FO. The overall expression of GHR-II 244 was of the same order of magnitude, but no significant changes in GHR transcripts were 245 detected with dietary treatments (Fig. 4B) . 246
Muscle expression of IGF-I was lower in comparison to that of IGF-II, and no 247 significant effect of dietary treatments on IGF-I mRNA levels were detected (Fig. 5A) . By 248 contrast, IGF-II mRNA was down-regulated in fish fed vegetable oils irrespective of the 249 degree of replacement (Fig. 5B) . 250
The overall muscle expression of GHR-I and II was of the same order of magnitude. 251
There was no consistent change on GHR-I mRNAs with dietary treatment (Fig. 6A) . By 252 contrast, transcripts of GHR-II were progressively up-regulated in fish fed 33VO and 66VO 253 diets, decreasing thereafter with the 100% of replacement of fish oil (VO diet) (Fig. 6B) . 254 255 4. Discussion 256
257
The overall growth indices attained in the current work by juvenile gilthead sea 258 bream are higher than those reported for fish of the same age under similar light and 259 temperature conditions (Gómez-Requeni et al., 2003 , 2004 . This excellent growth 260 performance in all experimental groups could be attributed to improved diet formulation, 261 fish management and culture conditions. However, fish fed the VO diet showed a reduced 262 feed intake and increased liver fat deposition, which is characteristic of a wide range of 263 dietary and hormonal imbalances (see McClain et al., 2004; Avramoglu et al., 2006) . This can be of special relevance during fasting and over-wintering, and extensive work is 268 now underway for this risk assessment. 269
Quantitative requirements of essential fatty acids (EFA) appear to vary depending 270 on fish species and growth stage (Sargent et al., 2002) . Thus, the biological demand for n-3 271 HUFA was at least 1.3% for flatfish larvae (Le Milinaire et al., 1983) , whereas 272 requirements for juvenile and grower fish were reduced to 0.8% (Gatesoupe et al., 1977; 273 Lee et al., 2003; Kim and Lee, 2004) and 0.6% (Lèger et al., 1979) Asian sea bass (Dyer et al., 2004) . Plasma IGF-I levels are also a good indicator of growth 293 in channel catfish (Silverstein et al., 2000; Li et al., 2006) . Similarly, in gilthead sea bream, 294 circulating GH and IGF-I are good markers of nutritional disorders arising from changes in 295 ration size (Pérez-Sánchez et al., 1995 , 2002 , dietary energy/ratio (Martí-Palanca et al., 296 1996; Company et al., 1999) and dietary protein source (Gómez-Requeni et al., 2003 , 297 2004 ). In the current work, the decreased growth of fish fed the VO diet were accordingly 298 paralleled by decreased plasma levels of IGF-I. Since IGF-I mRNA and GHR-I mRNA 299 were also reduced, the reduction in growth could be attributed to a transcriptional defect in 300 the signal transduction of GHR in spite of increased plasma levels of GH. This metabolic 301 feature leads to liver GH resistance as is now widely accepted in several fish species 302 (Pérez- Sánchez et al., 1995; Beckman et al., 2004; Pierce et al., 2005; Wilkinson et al., 303 2006) . 304
Growth in fish fed the VO diet (0.3% EPA + DHA; see Table 3 ) was only 90% of 305 the maximum observed, and there was no mortality in this group over the course of the 306 study. Similar results were reported for juvenile European sea bass fed defatted fish meal 307 diets (Skalli and Robin, 2004) , which suggests that marine fish are relatively tolerant to 308 dietary fish oil restriction despite of the recognized essentiality of n-3 HUFA. As stated 309 very early by Watanabe (1982) , the triacyglycerol and polar lipid fractions of lipids, both 310 containing adequate amounts of EPA and DHA, have the same EFA value. Takeuchi and 311 Watanabe (1979) have shown that a level of EFA exceeding four times the requirement of 312 rainbow trout leads to poor growth and feed utilisation. Detrimental growth effects have 313 also been reported in juvenile flounder when dietary n-3 HUFA becomes excessive (Kim 314 and Lee, 2004) , and 25% replacement of fish oil by palm oil fatty acid distillate improved 315 weight gain of African catfish (Ng et al., 2004) . In the present study, growth performance 316 of fish fed FO, 33VO and 66VO diets was almost identical, but the balance between 317 endocrine and locally produced IGFs differed depending on dietary treatment. Thus, in fish 318 fed the FO diet, the reduced gene expression and protein production of hepatic IGF-I was 319 apparently compensated by the increased expression of IGF-II at the local tissue level. 320
In mammals, IGF-II mRNA is detected in many fetal tissues but decreases quickly 321 during postnatal development (Daughaday and Rotwein, 1989) . Accordingly, IGF-II null 322 mice are small at birth but continue to growth postnatally at a rate similar to wild-type. By 323 contrast, IGF-I null mice born were small and most died in the early neonatal stages. ( Duguay et al., 1996; Radaelli et al., 2003) and confirmed here. Furthermore, as found for 334 IGF-I, the main site for fish IGF-II expression is the liver, but in contrast to IGF-I, other 335 organs such as skeletal muscle also express quite high levels of IGF-II mRNA. Thus, fast 336 growing families of channel catfish express hepatic and muscle IGF-II at a high rate 337 (Peterson et al., 2004) , and the growth spurt of juvenile rainbow trout during refeeding 338 could be mediated by muscle IGF-II (Chauvigné et al., 2003) . Accordingly, it is reasonable 339 to assume that IGF-II acts in fish as an important growth-promoting factor through all the 340 life cycle, although most of these regulatory capabilities might have been lost during the 341 evolution of higher vertebrates. 342
To our knowledge, the precise mechanism(s) regulating the relative contribution of 343 systemic and local IGFs on fish growth remains unexplored. However, we suspect that 344 some results of the current study could be mediated by factors other than dietary fatty acids. Transgenic models in mice also indicate that major effects of GH on growth are 365 dependent on IGF-I expression, which requires intact insulin and IGF-I receptor signalling 366 in skeletal muscle (Kim et al., 2005) . However, GH regulates other mitogenic factors, and 367 there is now experimental evidence supporting the up-regulated expression of GHRs during 368 muscle repair and maintenance (Casse et al., 2003) . In fish, it is believed that genetic 369 duplication and divergence of two GHR subtypes (GHR type I and II) would take place on 370 an early ancestor of fish lineage (Saera-Vila et al., 2005b; Jiao et al., 2006) . GHR-I was 371 first described in non-salmonid fish (Calduch-Giner et al., 2001) , conserving most of the 372 structural features of mammalian GHRs. By contrast, GHR-II (also named somatolactin 373 receptor by Fukada et al., 2005 ) is unique to teleosts and encompasses most of the 374 published GHR sequences of salmonid fish. These two GHR subtypes are conserved in a 375 wide range of fish species, although apparent silencing and/or genomic loss of GHR-II was 376 reported in the flatfish lineage with the occurrence of truncated variants of GHR-I (Pérez-377 Sánchez et al., 2002; Saera-Vila et al., 2005b) . In this scenario, the current study confirms 378 and extends the notion that major GH effects on growth and hepatic IGF expression are 379 mediated by GHR-I in gilthead sea bream. By contrast, GHR-II emerges as a more 380 constitutive gene that does not necessarily require intact IGF-pathways to exert a protective 381 and/or growth promoting action. This is consistent with the up-regulated expression of 382 GHR-II in skeletal muscle of fish fed the 66VO diet. In this way, we previously reported 383 that GHR-II is up-regulated in the skeletal muscle of fasted juvenile gilthead sea bream 384 
